Dose-finding Study of WS6788A, DS37-4 and H10407 Enterotoxigenic Escherichia Coli (ETEC) Challenge Strains

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

February 22, 2007

Study Completion Date

May 30, 2007

Conditions
Diarrhea
Interventions
BIOLOGICAL

H10407

The primary objective of the proposed clinical investigation is to validate a dose for ETEC H10407 that will cause diarrhea in 50% or more of subjects without causing high output diarrhea

Trial Locations (1)

21205

General Clinical Research Center, Baltimore

Sponsors
All Listed Sponsors
collaborator

Henry M. Jackson Foundation for the Advancement of Military Medicine

OTHER

collaborator

Naval Medical Research Center

FED

collaborator

Walter Reed Army Institute of Research (WRAIR)

FED

collaborator

U.S. Army Medical Research and Development Command

FED

lead

Johns Hopkins Bloomberg School of Public Health

OTHER

NCT00198796 - Dose-finding Study of WS6788A, DS37-4 and H10407 Enterotoxigenic Escherichia Coli (ETEC) Challenge Strains | Biotech Hunter | Biotech Hunter